These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

909 related items for PubMed ID: 23861222

  • 1. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
    Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, Shen J, Zhang J.
    Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
    Zhou Y, Li Y, Ye J, Jiang R, Yan H, Yang X, Liu Q, Zhang J.
    Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM.
    Oncogene; 2014 Jul 31; 33(31):4069-76. PubMed ID: 24013226
    [Abstract] [Full Text] [Related]

  • 4. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
    Yang X, Ye J, Yan H, Tang Z, Shen J, Zhang J, Yang L.
    Tumour Biol; 2016 Jan 31; 37(1):201-9. PubMed ID: 26188902
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY, Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT.
    Hepatology; 2015 Sep 31; 62(3):801-15. PubMed ID: 25953743
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 8. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y, Wang J, Han J, Luo D, Sun Z.
    Exp Cell Res; 2017 Nov 15; 360(2):210-217. PubMed ID: 28890291
    [Abstract] [Full Text] [Related]

  • 9. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
    Jin B, Wang W, Meng XX, Du G, Li J, Zhang SZ, Zhou BH, Fu ZH.
    BMC Cancer; 2016 Nov 08; 16(1):863. PubMed ID: 27821157
    [Abstract] [Full Text] [Related]

  • 10. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 08; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 11. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP, Wang CY, Jin XH, Li M, Wang FW, Huang WJ, Yun JP, Xu RH, Cai QQ, Xie D.
    Theranostics; 2019 Mar 08; 9(7):1965-1979. PubMed ID: 31037150
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
    Shen G, Lin Y, Yang X, Zhang J, Xu Z, Jia H.
    BMC Cancer; 2014 Jun 02; 14():393. PubMed ID: 24890815
    [Abstract] [Full Text] [Related]

  • 13. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
    Jiang F, Mu J, Wang X, Ye X, Si L, Ning S, Li Z, Li Y.
    PLoS One; 2014 Jun 02; 9(5):e96698. PubMed ID: 24806207
    [Abstract] [Full Text] [Related]

  • 14. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H, Dadpay M, Yahaghi E, Pirzaman ER, Fayyaz AF, Darian EK, Mokarizadeh A.
    Diagn Pathol; 2015 Aug 07; 10():135. PubMed ID: 26248880
    [Abstract] [Full Text] [Related]

  • 15. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.
    Fan Q, He M, Deng X, Wu WK, Zhao L, Tang J, Wen G, Sun X, Liu Y.
    Cell Biochem Funct; 2013 Jun 07; 31(4):319-24. PubMed ID: 23001723
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H, Ooi LL, Hui KM.
    Hepatology; 2013 Aug 07; 58(2):629-41. PubMed ID: 23471579
    [Abstract] [Full Text] [Related]

  • 17. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J, Liu Z, Wang Y, Wang L, Yao B, Li Q, Wang C, Tu K, Liu Q.
    Biomed Pharmacother; 2017 Sep 07; 93():420-428. PubMed ID: 28666208
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX, Zhang ZG, Ding ZY, Liang HF, Song J, Tan XL, Wu JJ, Li GZ, Zeng Z, Zhang BX, Chen XP.
    Oncotarget; 2016 Apr 19; 7(16):22674-86. PubMed ID: 26993767
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells.
    Xu W, Ji J, Xu Y, Liu Y, Shi L, Liu Y, Lu X, Zhao Y, Luo F, Wang B, Jiang R, Zhang J, Liu Q.
    Mol Carcinog; 2015 Jun 19; 54 Suppl 1():E148-61. PubMed ID: 25252218
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yao B, Li Y, Wang L, Chen T, Niu Y, Liu Q, Liu Z.
    Artif Cells Nanomed Biotechnol; 2019 Dec 19; 47(1):3885-3895. PubMed ID: 31561723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.